The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 2824-2831

  Jones, Simon ^a   Horwood, Nicole ^a   Cope, Andrew ^a   Dazzi, Francesco ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL CONTACT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE ACTIVATION; CELL CYCLE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL; T LYMPHOCYTE;

APOPTOSIS; CELL CYCLE; HUMANS; IMMUNOSUPPRESSION; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; STROMAL CELLS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449121250     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.2824     Document Type: Article

References (45)

1. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
2. Campagnoli, C., I. A. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk. 2001. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402.
3. Da Silva Meirelles, L., P. C. Chagastelles, and N. B. Nardi. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119: 2204-2213.
4. De Bari, C., F. Dell'Accio, P. Tylzanowski, and F. P. Luyten. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44: 1928-1942.
5. Sakaguchi, Y., I. Sekiya, K. Yagishita, and T. Muneta. 2005. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 52: 2521-2529.
6. Zuk, P. A., M. Zhu, P. Ashjian, D. A. De Ugarte, J. I. Huang, H. Mizuno, Z. C. Alfonso, J. K. Fraser, P. Benhaim, and M. H. Hedrick. 2002. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13: 4279-4295.
7. Uccelli, A., L. Moretta, and V. Pistoia. 2006. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36: 2566-2573.
8. Glennie, S., I. Soeiro, P. J. Dyson, E. W. Lam, and F. Dazzi. 2005. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105: 2821-2827.
9. Di Nicola, M., C. Carlo-Stella, M. Magni, M. Milanesi, P. D. Longoni, P. Matteucci, S. Grisanti, and A. M. Gianni. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
10. Krampera, M., S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi. 2003. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101: 3722-3729.
11. Corcione, A., F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, and A. Uccelli. 2006. Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372.
12. Spaggiari, G. M., A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta. 2006. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107: 1484-1490.
13. Aggarwal, S., and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
14. Ramasamy, R., H. Fazekasova, E. W. Lam, I. Soeiro, G. Lombardi, and F. Dazzi. 2007. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83: 71-76.
15. Meisel, R., A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo. 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621.
16. Sato, K., K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa. 2007. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109: 228-234.
17. Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, et al. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30: 42-48.
18. Zappia, E., S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, F. Frassoni, et al. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 106: 1755-1761.
19. Ringden, O., M. Uzunel, I. Rasmusson, M. Remberger, B. Sundberg, H. Lonnies, H. U. Marschall, A. Dlugosz, A. Szakos, Z. Hassan, et al. 2006. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81: 1390-1397.
20. Ramasamy, R., E. W. Lam, I. Soeiro, V. Tisato, D. Bonnet, and F. Dazzi. 2007. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21: 304-310.
21. Le Blanc, K., I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel, and O. Ringden. 2004. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
22. Dazzi, F., R. Ramasamy, S. Glennie, S. P. Jones, and I. Roberts. 2006. The role of mesenchymal stem cells in hemopoiesis. Blood Rev. 20: 161-171.
23. Devine, S. M., C. Cobbs, M. Jennings, A. Bartholomew, and R. Hoffman. 2003. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101: 2999-3001.
24. Li, Y., H. Hisha, M. Inaba, Z. Lian, C. Yu, M. Kawamura, Y. Yamamoto, N. Nishio, J. Toki, H. Fan, and S. Ikehara. 2000. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp. Hematol. 28: 950-960.
25. Chang, H. Y., J. T. Chi, S. Dudoit, C. Bondre, M. van de Rijn, D. Botstein, and P. O. Brown. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. USA 99: 12877-12882.
26. Parsonage, G., F. Falciani, A. Burman, A. Filer, E. Ross, M. Bofill, S. Martin, M. Salmon, and C. D. Buckley. 2003. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb. Haemostasis 90: 688-697.
27. Parsonage, G., A. D. Filer, O. Haworth, G. B. Nash, G. E. Rainger, M. Salmon, and C. D. Buckley. 2005. A stromal address code defined by fibroblasts. Trends Immunol. 26: 150-156.
28. Smith, T. J. 2005. Insights into the role of fibroblasts in human autoimmune diseases. Clin. Exp. Immunol. 141: 388-397.
29. Huber, L. C., O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45: 669-675.
30. Prabhakar, B. S., R. S. Bahn, and T. J. Smith. 2003. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev. 24: 802-835.
31. Joannides, A. J., C. Fiore-Heriche, A. A. Battersby, P. Athauda-Arachchi, I. A. Bouhon, L. Williams, K. Westmore, P. J. Kemp, A. Compston, N. D. Allen, and S. Chandran. 2007. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25: 731-737.
32. Le Blanc, K., C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringden. 2003. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31: 890-896.
33. Liu, H., D. M. Kemeny, B. C. Heng, H. W. Ouyang, A. J. Melendez, and T. Cao. 2006. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J. Immunol. 176: 2864-2871.
34. Bocelli-Tyndall, C., A. Barbero, C. Candrian, R. Ceredig, A. Tyndall, and I. Martin. 2006. Human articular chondrocytes suppress in vitro proliferation of anti-CD3 activated peripheral blood mononuclear cells. J. Cell. Physiol. 209: 732-734.
35. Groh, M. E., B. Maitra, E. Szekely, and O. N. Koc. 2005. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 33: 928-934.
36. Krampera, M., L. Cosmi, R. Angeli, A. Pasini, F. Liotta, A. Andreini, V. Santarlasci, B. Mazzinghi, G. Pizzolo, F. Vinante, et al. 2006. Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398.
37. Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219.
38. Buckley, C. D., D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22: 199-204.
39. Burman, A., O. Haworth, P. Bradfield, G. Parsonage, A. Filer, A. M. Thomas, N. Amft, M. Salmon, and C. D. Buckley. 2005. The role of leukocyte-stromal interactions in chronic inflammatory joint disease. Joint Bone Spine 72: 10-16.
40. Djouad, F., V. Fritz, F. Apparailly, P. Louis-Plence, C. Bony, J. Sany, C. Jorgensen, and D. Noel. 2005. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis Rheum. 52: 1595-1603.
41. Pilling, D., A. N. Akbar, J. Girdlestone, C. H. Orteu, N. J. Borthwick, N. Amft, D. Scheel-Toellner, C. D. Buckley, and M. Salmon. 1999. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29: 1041-1050.
42. Filer, A., G. Parsonage, E. Smith, C. Osborne, A. M. Thomas, S. J. Curnow, G. E. Rainger, K. Raza, G. B. Nash, J. Lord, et al. 2006. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum. 54: 2096-2108.
43. + T cells: a mechanism of immunoregulation? J. Immunol. 165: 4182-4189.
44. Warrens, A. N., J. Y. Zhang, S. Sidhu, D. J. Watt, G. Lombardi, C. A. Sewry, and R. I. Lechler. 1994. Myoblasts fail to stimulate T cells but induce tolerance. Int. Immunol. 6: 847-853.
45. Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, et al. 2003. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425: 841-846.